NYSE:MDT - Medtronic Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $86.64 -0.66 (-0.76 %) (As of 01/22/2019 12:18 PM ET)Previous Close$87.30Today's Range$86.00 - $86.997752-Week Range$76.41 - $100.15Volume1.61 million shsAverage Volume6.39 million shsMarket Capitalization$117.25 billionP/E Ratio18.16Dividend Yield2.29%Beta0.93 ProfileDiscussionAnalyst RatingsChartDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Medtronic plc develops, manufactures, distributes, and sells device-based medical therapies to hospitals, physicians, clinicians, and patients worldwide. It operates through four segments: Cardiac and Vascular Group, Minimally Invasive Therapies Group, Restorative Therapies Group, and Diabetes Group. The Cardiac and Vascular Group segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; AF ablation product; insertable cardiac monitor systems; mechanical circulatory support; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves; percutaneous coronary intervention stents, surgical valve replacement and repair products, endovascular stent grafts, percutaneous angioplasty balloons, and products to treat superficial venous diseases in the lower extremities. The Minimally Invasive Therapies Group segment offers surgical products, including surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, hernia mechanical devices, mesh implants, and gynecology products; hardware instruments and mesh fixation device; and gastrointestinal, inhalation therapy, and renal care solutions. The Restorative Therapies Group segment offers products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, colorectal surgeons, urogynecologists, interventional radiologists, and ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems; and therapies for vasculature in and around the brain. The Diabetes Group segment offers insulin pumps and consumables, continuous glucose monitoring systems, and therapy management software. The company was founded in 1949 and is headquartered in Dublin, Ireland. Receive MDT News and Ratings via Email Sign-up to receive the latest news and ratings for MDT and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NYSE Industry Electromedical equipment Sub-IndustryHealth Care Equipment SectorMedical Current SymbolNYSE:MDT Previous Symbol CUSIP58505510 Webwww.medtronic.com Phone353-1438-1700Debt Debt-to-Equity Ratio0.48 Current Ratio2.56 Quick Ratio2.11Price-To-Earnings Trailing P/E Ratio18.16 Forward P/E Ratio16.89 P/E Growth2.28 Sales & Book Value Annual Sales$29.95 billion Price / Sales3.88 Cash Flow$6.7059 per share Price / Cash Flow12.92 Book Value$37.50 per share Price / Book2.31Profitability EPS (Most Recent Fiscal Year)$4.77 Net Income$3.10 billion Net Margins7.44% Return on Equity13.51% Return on Assets7.45%Miscellaneous Employees86,000 Outstanding Shares1,343,050,000Market Cap$117.25 billion OptionableOptionable Medtronic (NYSE:MDT) Frequently Asked Questions What is Medtronic's stock symbol? Medtronic trades on the New York Stock Exchange (NYSE) under the ticker symbol "MDT." How often does Medtronic pay dividends? What is the dividend yield for Medtronic? Medtronic announced a quarterly dividend on Friday, December 7th. Investors of record on Friday, December 28th will be paid a dividend of $0.50 per share on Friday, January 18th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.31%. The ex-dividend date is Thursday, December 27th. View Medtronic's Dividend History. How will Medtronic's stock buyback program work? Medtronic declared that its board has authorized a stock buyback program on Thursday, October 5th 2017, which allows the company to repurchase $5,000,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization allows the company to buy up to 49% of its shares through open market purchases. Shares repurchase programs are typically an indication that the company's board of directors believes its stock is undervalued. How were Medtronic's earnings last quarter? Medtronic PLC (NYSE:MDT) issued its quarterly earnings data on Tuesday, November, 20th. The medical technology company reported $1.22 EPS for the quarter, beating the Thomson Reuters' consensus estimate of $1.15 by $0.07. The medical technology company had revenue of $7.48 billion for the quarter, compared to the consensus estimate of $7.35 billion. Medtronic had a net margin of 7.44% and a return on equity of 13.51%. The company's quarterly revenue was up 6.1% on a year-over-year basis. During the same period last year, the business posted $1.07 EPS. View Medtronic's Earnings History. When is Medtronic's next earnings date? Medtronic is scheduled to release their next quarterly earnings announcement on Tuesday, February 19th 2019. View Earnings Estimates for Medtronic. What guidance has Medtronic issued on next quarter's earnings? Medtronic updated its third quarter earnings guidance on Tuesday, November, 20th. The company provided earnings per share (EPS) guidance of $1.23-1.25 for the period. Medtronic also updated its FY 2019 guidance to $5.10-5.15 EPS. What price target have analysts set for MDT? 22 Wall Street analysts have issued 12 month price objectives for Medtronic's stock. Their forecasts range from $88.00 to $120.00. On average, they anticipate Medtronic's share price to reach $104.1429 in the next year. This suggests a possible upside of 20.4% from the stock's current price. View Analyst Price Targets for Medtronic. What is the consensus analysts' recommendation for Medtronic? 22 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Medtronic in the last year. There are currently 7 hold ratings, 14 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Medtronic. Has Medtronic been receiving favorable news coverage? Press coverage about MDT stock has been trending very positive recently, according to InfoTrie Sentiment. The research group scores the sentiment of news coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Medtronic earned a media sentiment score of 3.2 on InfoTrie's scale. They also assigned news stories about the medical technology company a news buzz of 4.0 out of 10, meaning that recent news coverage is somewhat unlikely to have an impact on the company's share price in the next several days. Who are some of Medtronic's key competitors? Some companies that are related to Medtronic include SONOVA HLDG AG/ADR (SONVY), Varian Medical Systems (VAR), Masimo (MASI), LivaNova (LIVN), GETINGE AB/ADR (GNGBY), NxStage Medical (NXTM), CONMED (CNMD), Natus Medical (BABY), Viewray (VRAY), AxoGen (AXGN), Semler Scientific (SMLR), BioLife Solutions (BLFS), Cutera (CUTR), Rockwell Medical (RMTI) and Electrocore (ECOR). Who are Medtronic's key executives? Medtronic's management team includes the folowing people: Mr. Omar S. Ishrak, Chairman & CEO (Age 63)Ms. Karen L. Parkhill, Exec. VP, CFO & Principal Accounting Officer (Age 54)Mr. Bradley E. Lerman, Sr. VP, Gen. Counsel & Company Sec. (Age 62)Mr. Michael J. Coyle, Exec. VP and Group Pres of Cardiac & Vascular Group (Age 57)Mr. Robert J. W. ten Hoedt, Exec. VP and Group Pres, Europe, Middle East & Africa (Age 58) Who are Medtronic's major shareholders? Medtronic's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Factory Mutual Insurance Co. (0.09%), Gateway Investment Advisers LLC (0.08%), Hexavest Inc. (0.08%), Cornerstone Investment Partners LLC (0.06%), Nisa Investment Advisors LLC (0.04%) and Atalanta Sosnoff Capital LLC (0.04%). Company insiders that own Medtronic stock include Bradley E Lerman, Bryan C Hanson, Carol A Surface, Geoffrey Martha, Hoedt Rob Ten, Hooman Hakami, James T Lenehan, Karen L Parkhill, Michael J Coyle, Omar Ishrak, Richard H Anderson and Richard Kuntz. View Institutional Ownership Trends for Medtronic. Which major investors are selling Medtronic stock? MDT stock was sold by a variety of institutional investors in the last quarter, including Hexavest Inc., Riverbridge Partners LLC, Oakbrook Investments LLC, Cornerstone Investment Partners LLC, Saratoga Research & Investment Management, Community Trust & Investment Co., Virtu Financial LLC and Louisiana State Employees Retirement System. Company insiders that have sold Medtronic company stock in the last year include Bradley E Lerman, Carol A Surface, Geoffrey Martha, Hooman Hakami, James T Lenehan, Michael J Coyle and Richard Kuntz. View Insider Buying and Selling for Medtronic. Which major investors are buying Medtronic stock? MDT stock was bought by a variety of institutional investors in the last quarter, including Factory Mutual Insurance Co., Atalanta Sosnoff Capital LLC, Sit Investment Associates Inc., SG Capital Management LLC, Farmers Trust Co., Centre Asset Management LLC, Hotaling Investment Management LLC and Advisors Capital Management LLC. Company insiders that have bought Medtronic stock in the last two years include Karen L Parkhill, Omar Ishrak and Richard H Anderson. View Insider Buying and Selling for Medtronic. How do I buy shares of Medtronic? Shares of MDT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Medtronic's stock price today? One share of MDT stock can currently be purchased for approximately $86.49. How big of a company is Medtronic? Medtronic has a market capitalization of $117.25 billion and generates $29.95 billion in revenue each year. The medical technology company earns $3.10 billion in net income (profit) each year or $4.77 on an earnings per share basis. Medtronic employs 86,000 workers across the globe. What is Medtronic's official website? The official website for Medtronic is http://www.medtronic.com. How can I contact Medtronic? Medtronic's mailing address is 20 ON HATCH LOWER HATCH STREET, DUBLIN L2, D02. The medical technology company can be reached via phone at 353-1438-1700 or via email at [email protected] MarketBeat Community Rating for Medtronic (NYSE MDT)Community Ranking: 3.1 out of 5 ( )Outperform Votes: 1,133 (Vote Outperform)Underperform Votes: 691 (Vote Underperform)Total Votes: 1,824MarketBeat's community ratings are surveys of what our community members think about Medtronic and other stocks. Vote "Outperform" if you believe MDT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MDT will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 1/22/2019 by MarketBeat.com StaffFeatured Article: What is the price-sales ratio?